Frontotemporal dementia and Parkinsonism linked to chromosome 17: a new group of tauopathies.

Brain Pathology
Maria Grazia SpillantiniBernardino Ghetti

Abstract

Frontotemporal dementia is a neurological disorder characterised by personality changes, deterioration of memory and executive functions as well as stereotypical behaviour. Sometimes a Parkinsonian syndrome is prominent. Several cases of frontotemporal dementia are hereditary and recently families have been identified where the disease is linked to chromosome 17q21-22. Although, there is clinical and neuropathological variability among and within families, they all consistently present a symptomathology that has led investigators to name the disease "Frontotemporal Dementia and Parkinsonism linked to chromosome 17." Neuropathologically, these patients present with atrophy of frontal and temporal cortex as well as of basal ganglia and substantia nigra. In the majority of cases these features are accompanied by neuronal loss, gliosis and microtubule-associated protein tau deposits which can be present in both neurones and glial cells. The distribution, structural and biochemical characteristics of the tau deposits differentiate them from those present in Alzheimer's disease, corticobasal degeneration, progressive supranuclear palsy and Pick's disease. No beta-amyloid deposits are present. The clinical and neuropathological featur...Continue Reading

References

Nov 3, 1992·Biochemistry·A AndreadisK S Kosik
Mar 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·R A Crowther
Jan 1, 1991·Acta Neuropathologica·H Braak, E Braak
Aug 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·S G Greenberg, P Davies
Oct 1, 1968·Journal of Neurology, Neurosurgery, and Psychiatry·H H Schaumburg, K Suzuki
Oct 1, 1984·Annals of Neurology·J C MorrisD Wright
Mar 1, 1981·Brain : a Journal of Neurology·R C KimY B Chu
Oct 1, 1995·Brain : a Journal of Neurology·J G de YébenesA J Lees
Jan 1, 1995·Acta Neuropathologica·P GiannakopoulosC Bouras
Jun 1, 1995·Neurology·R B PetersenT ] Lynches T [corrected to Lynch
Sep 1, 1994·Neurology·D J LanskaW R Markesbery
May 1, 1993·Journal of Neurology, Neurosurgery, and Psychiatry·J BrownM Rossor
Jun 1, 1993·Journal of Neurology, Neurosurgery, and Psychiatry·D M MannD Neary
Sep 1, 1995·Human Molecular Genetics·J BrownJ Collinge
May 1, 1996·Journal of Neuropathology and Experimental Neurology·S S Chin, J E Goldman
May 1, 1996·Journal of Neuropathology and Experimental Neurology·M L SchmidtJ Q Trojanowski
Jun 1, 1996·Annals of Neurology·A A SimaK C Wilhelmsen
Jan 1, 1996·Acta Neuropathologica·M Jackson, J Lowe
Jun 1, 1996·Neurobiology of Disease·R E TanziW Wasco
Feb 1, 1997·Annals of Neurology·K C Wilhelmsen
Feb 1, 1997·The Australian and New Zealand Journal of Psychiatry·F Dark
Apr 15, 1997·Proceedings of the National Academy of Sciences of the United States of America·M G SpillantiniB Ghetti

❮ Previous
Next ❯

Citations

Aug 6, 1999·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·M Goedert
Aug 4, 1999·Brain : a Journal of Neurology·S RahmanT W Robbins
Jan 29, 2000·Brain : a Journal of Neurology·M N RossorE K Warrington
Apr 18, 2001·Journal of Neuropathology and Experimental Neurology·E H BigioD W Dickson
Nov 15, 2002·Journal of Neuropathology and Experimental Neurology·D W DicksonUNKNOWN Office of Rare Diseases of the National Institutes of Health
Aug 5, 2003·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Susanne Froelich FabreLars Lannfelt
Sep 23, 2003·Movement Disorders : Official Journal of the Movement Disorder Society·Tamas Revesz, Janice L Holton
Mar 5, 2005·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Qin WangThomas J Montine
Jun 26, 2010·Journal of Magnetic Resonance Imaging : JMRI·JiunJie WangChin-Song Lu
Sep 19, 2012·Proceedings of the National Academy of Sciences of the United States of America·Peng WangJohn A Hanover
Nov 18, 2014·Neuropathology and Applied Neurobiology·F ClavagueraM Tolnay
Aug 10, 2016·Journal of Neurochemistry·Eva-Maria Hock, Magdalini Polymenidou
Jul 18, 2017·Frontiers in Molecular Neuroscience·Cristina Di PrimioAntonino Cattaneo
Dec 6, 2017·International Review of Psychiatry·Mikaeel Valli, Antonio P Strafella
May 3, 2019·Science Translational Medicine·Atsushi AoyagiStanley B Prusiner
May 16, 2019·The Journal of Immunology : Official Journal of the American Association of Immunologists·Cecilia S Lindestam ArlehamnAlessandro Sette
May 1, 2019·Brain : a Journal of Neurology·Marie AlbertMorvane Colin
Jul 30, 2020·International Journal of Molecular Sciences·Darius VagrysBen Davis
Oct 12, 1999·Brain Pathology·S H YenP Nacharaju
Apr 11, 2001·Movement Disorders : Official Journal of the Movement Disorder Society·J M HendersonG M Halliday
Jul 27, 1999·Neuropathology and Applied Neurobiology·M Tolnay, A Probst
Jul 6, 2000·FEBS Letters·J Avila
Oct 10, 2002·Annals of Medicine·Martin Ingelsson, Bradley T Hyman
Apr 12, 2001·Arquivos de neuro-psiquiatria·P R Brito-MarquesL Montenegro
Mar 16, 2007·Journal of Neuropathology and Experimental Neurology·Manuela NeumannVirginia M-Y Lee
Mar 7, 2008·Neuro-degenerative Diseases·Benjamin WolozinMisha Riley
Apr 13, 2007·Neuro-degenerative Diseases·Verena H Finder, Rudi Glockshuber
Jun 30, 2006·Journal of Neurochemistry·Colin L MastersVictor L Villemagne
Jul 4, 2006·NeuroRx : the Journal of the American Society for Experimental NeuroTherapeutics·Stephen D GinsbergElliott J Mufson
May 27, 2011·Acta Neuropathologica·Keith A JosephsDennis W Dickson
Jun 1, 2011·Journal of Molecular Neuroscience : MN·Alexandra M NicholsonRosa Rademakers
Jul 26, 2011·Journal of Molecular Neuroscience : MN·Michel Goedert, Maria Grazia Spillantini
Jun 18, 2010·CNS Neuroscience & Therapeutics·Rodrigo MedeirosFrank M LaFerla
Aug 1, 2014·Frontiers in Molecular Neuroscience·Taeko KimuraShin-Ichi Hisanaga
Aug 15, 2012·Acta Neuropathologica·Anne SiebenMarc Cruts
Sep 25, 2015·Journal of Alzheimer's Disease : JAD·Davide GuidoBarbara Borroni

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal ganglia in Parkinson's disease (MDS)

The basal ganglia is comprised of the neostriatum, the external and internal pallidal segments, the subthalamic nucleus, the substantia nigra pars reticulata, and the pars compacta of the substantia nigra. The basal ganglia circuitry is responsible for the correct execution of voluntary movements and is implicated in Parkinson's disease. Here is the latest research investigating the basal ganglia in Parkinson's disease.

Astrocytes & Amyloid

Astrocytes are thought to play a role in amyloid production and have been implicated in neurodegenerative diseases such as Alzheimer’s disease. Here is the latest research on the relationship between astrocytes and amyloid.

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a neurodegenerative disease. This feed focuses on the underlying role of tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's disease.

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Related Papers

Neuropathology : Official Journal of the Japanese Society of Neuropathology
Yoshio Tsuboi
European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies
L SkoglundR Herva
© 2022 Meta ULC. All rights reserved